TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
13/08/2026
Voltar para busca
Dado oficial do USPTO
CELLECTIS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
CELLECTIS
ST13
US500000076210655Classe
1, 5, 9, 42
Pedido
76210655
Registro
2872075
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
52
Atualização mais recente
14/08/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 9, 42
Data de depósito
13/02/2001
Data de registro
10/08/2004
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
13/11/2024
Última transação
14/08/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
2001-09-00
Primeiro uso no comércio
2001-09-00
Código do desenho
1
Tipo de titular
16
Localização do titular
Paris, FR
Examinador
CHARLON, BARNEY
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Cellectis S.A.
Cellectis S.A.
Representantes
Mary Margaret L. O'Donnell Blue Filament Law PLLC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicalbiochemicalbiotechnological products intended for industryagriculturehorticulturenamely polypeptides for in vivo and in vitro genetic engineeringnatural and engineered meganucleases and endonucleasesnucleic acid vectorsmolecular scissors; ready to use genomic recombination systemmeganuclease recombination agents for use in genetic engineering of cells and animalsnamely rodent and fishfor scientificlaboratory or medical research; chemicalbiochemicalbiotechnological and bacteriological products intended for research laboratories and control laboratoriesnamely polypeptides for in vivo and in vitro genetic engineeringnatural and engineered meganucleases and endonucleasesnucleic acid vectorsmolecular scissorsready to use genomic recombination agents for use in connection with cells and animals for scientificlaboratory or medical research; chemicalbiochemicalbiotechnological products and bacteriological preparations for sciencesnamely polypeptides for in vivo and in vitro genetic engineering; natural and engineered meganucleases and endonucleasesnucleic acid vectorsmolecular scissorsready to use genomic recombination agents for use in connection with cells and animals for scientificlaboratory or medical research; diagnostic preparationnamely natural and engineered meganucleases and endonucleasesmolecular scissors for scientific or research use; proteins as raw materials; microorganisms used for producing therapeutical compounds or vaccines; chemical and biochemical preparations for medicalpharmaceutical and veterinary usenamely polypeptides for in vivo and in vitro genetic engineeringnatural and engineered meganucleases and endonucleasesnucleic acid vectorsmolecular scissorsready to use genomic recombination agents for scientific or research use
Classe 5
Pharmaceuticalveterinary and health-care productsnamely polypeptides for in vivo and in vitro genetic engineeringnatural and engineered meganucleases and endonucleasesnucleic acid vectorsmolecular scissorsready to use genomic recombination systemcells engineered by meganulease recombination system for use in genetic or viral diseases; microorganism cultures and preparation for medicalpharmaceutical and veterinary usenamely microoganisms engineered by meganuclease recombination system for use in genetic or viral diseasescancers and vaccines; microorganisms producing polypeptides for in vivo and vitro genetic engineeringnatural and engineered meganucleases and endonucleasesnucleic acid vectorsmolecular scissorsready to use genomic recombination system for use in genetic or viral diseases; bacteriological preparations for medicalpharmaceutical and veterinary use namely bacteriological preparations engineered by meganuclease recombination system; bacteriological preparations producing polypeptides for in vivo and in vitro genetic engineeringnatural and engineered meganucleases and endonucleasesnucleic acid vectorsmolecular scissorsready to use genomic recombination system; drugs for veterinary usenamely polypeptides for in vivo and in vitro genetic engineeringnatural and engineered meganucleases and endonucleasesnucleic and acid vectorsmolecular scissors for use in genetic or viral diseases; biological preparation for medicalpharmaceutical and veterinary use namely polypeptides for in vivo and in vitro genetic engineeringnatural and engineered meganucleases and endonucleaesnucleic and vectorsmolecular scissorsready to use genomic recombination systemcells engineered by meganuclease recombination system for use in genetic or viral diseases; chemopharmaceutical preparations; diagnostic preparations for clinical or medical laboratory use
Classe 9
Scientific devices and instruments enabling implementation of biochemical analysis techniques and molecular biology techniquesnamely automated biochemical analyserautomated protein production and protein purification devicesbiochemicalbiological automated assay devicesnucleic acid break analyseranalyzer for automatically measuring and researching interactions of biomoleculesdevice for protein-nucleic acid interaction analysis; apparatus for use in analysis and array-testsqualitative and quantitative detection of analytes in samplesDNA sequencingreceptor-ligand interactionprotein analysismass-spectrometrynucleic acid hybridization and detectionthermo-cycler systemsmicroarray-printermicroarray-reader; scientific devices and instruments enabling the mapping of the biological activities of all molecules; information processing equipmentcomputer software for molecular designsequence analysissequence generationdesign and analysis for moleculesnamely polypeptides or polynucleotides used in genetic engineeringdesign and analysis of meganucleases and endonucleases and for design and analysis of genetic recombination systemshardware and component partsprocessorsmemory banksperipheral controllers; multimedia productsprerecorded magnetic tapesCD-ROMscontaining image and sound recordings in the fields of chemistrybiologybiochemistrymolecular biologybacteriology; software programs namelysoftware for providing an on-line computer database in the field of pharmaceuticals and biotechnology; software for searchingretrievingstoringmaintaining and managing data in the field of pharmaceuticals and biotechnology; software for use in the field of scientific information management; software for use in drug discovery; software for biomolecules analysisnucleic acids and proteins sequences evaluationchemicalmedical and biological data bank searches and analysisphysiological data analysisgenetic data analysischemical formulae analysisstructural prediction for biological and chemical molecules; software for writing biological molecule sequence; molecular design software for analysissimulation and design of biologicalchemicalmaterial systems; software for molecular design in the biotechnology and pharmaceutical field; software for use in biological and chemical modelinganalysis and information management; software for integrated global management
Classe 42
Scientific and industrial research; research in geneticmedicalpharmaceutical and veterinary fields; research in chemistrybiologybiochemistrymolecular biologybacteriology; scientific analysis; research and development for others of techniques of biochemical analysisbiological analysismolecular biology techniques; research and development for others of new molecules intended for industry; laboratory research in the fields of biotechnologyhuman and veterinary medicinegenetic engineeringprotein designdrug designgenetic therapymolecular biologyagriculture; medical services; studies of technical projects in the field of biotechnologyhuman and veterinary medicinegenetic engineeringprotein designdrug designgenetic therapymolecular biologyagriculture; testinganalysis and evaluation of engineering works for others; licensing of patents and intellectual property; computer programming for othersdevelopment for others of multimedia software programs
Publicações
Histórico de despachos e eventos da marca no USPTO.
52 publicações encontradas
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
13/08/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
13/08/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
13/08/2026
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
13/11/2024
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
13/11/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
13/11/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/11/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
12/08/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
18/10/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
18/10/2023
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
18/10/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
18/10/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
18/10/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
18/10/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
18/10/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
10/08/2023
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
12/02/2015
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
12/02/2015
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
12/02/2015
E89R
TEAS SECTION 8 & 9 RECEIVED
10/02/2015
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/02/2015
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/02/2015
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
27/08/2010
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
27/08/2010
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
06/08/2010
E815
TEAS SECTION 8 & 15 RECEIVED
06/08/2010
R.PR
REGISTERED-PRINCIPAL REGISTER
10/08/2004
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/06/2004
DOCK
ASSIGNED TO EXAMINER
26/05/2004
SUPC
STATEMENT OF USE PROCESSING COMPLETE
26/05/2004
CFIT
CASE FILE IN TICRS
21/05/2004
IUAF
USE AMENDMENT FILED
11/05/2004
FAXX
FAX RECEIVED
11/05/2004
PAPER RECEIVED
11/05/2004
EX1G
SOU EXTENSION 1 GRANTED
09/12/2003
EXT1
SOU EXTENSION 1 FILED
13/11/2003
PAPER RECEIVED
13/11/2003
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
13/05/2003
PUBO
PUBLISHED FOR OPPOSITION
18/02/2003
NPUB
NOTICE OF PUBLICATION
29/01/2003
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
16/12/2002
CNEA
EXAMINERS AMENDMENT MAILED
22/11/2002
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
21/11/2002
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
21/11/2002
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/09/2002
PAPER RECEIVED
30/09/2002
CNFR
FINAL REFUSAL MAILED
20/05/2002
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/11/2001
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
19/11/2001
CNRT
NON-FINAL ACTION MAILED
15/06/2001
DOCK
ASSIGNED TO EXAMINER
12/06/2001
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CELLECTIS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.